Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 1, 2026 · Other material event
ONCOLYTICS BIOTECH INC
7
Other material event
Jun 1, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | ONCOLYTICS BIOTECH INC filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. Oncolytics Biotech ® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches Early results from solid tumor model support additional studies in pancreatic and colorectal cancer models; full dataset planned for presentation later in 2026 SAN DIEGO, CA, June 1, 2026 – Oncolytics Bi… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 1, 2026 |
| Accession number | 0001129928-26-000037 |
| Reported items | Other events the company considers material See Analysis tab for workforce implications |
